Clinical Trials in Miami

Showing 4021-4040 of 11,431 trials

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

NCT05607979

This is an IRB-approved multicenter study.This non-inferiority study aims to evaluate differential healing rates between Lavior Diabetic Wound Gel and other Hydrogels. Study therapy will be started in the outpatient setting and followed accordingly.

Diabetic Foot Ulcer

Lavior Pharma Inc.75 participantsStarted Dec 2022

Miami, Florida, United States

TERMINATEDPhase 3< 1 mile

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

NCT05479058

Participants who were in clinical remission on 200 milligram (mg) filgotinib once daily for at least 2 consecutive quarterly visits in the ongoing SELECTION-LTE study (GS-US-418-3899, NCT02914535), were planned to be rolled over and randomized in this study. The primary objective of this study was to evaluate the efficacy of filgotinib in participants in stable clinical remission on 200 mg filgotinib once daily for whom the dose was decreased to 100 mg once daily compared to participants remaining on 200 mg once daily.

Ulcerative Colitis

Galapagos NV22 participantsStarted Jul 2022

Miami, Florida, United States • Naples, Florida, United States • Columbia, Maryland, United States +47 more locations

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Find Trials by Condition in Miami

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Observational Study of Obstructive Lung Disease (NOVELTY)

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

SMR Stemless Reverse Vs SMR Reverse Shoulder System

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study

A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma